SAN JOSE, CALIF--() April 22, 2013 -- Intermolecular, Inc. (Nasdaq:IMI) announces today that Epistar, Corp. (TWSE:2448) and Intermolecular, Inc. (Nasdaq:IMI), have signed a collaborative development program (CDP) and royalty-bearing IP licensing agreement to increase the efficiency and reduce cost of Epistar‘s light emitting diode (LED) devices. Under this agreement, Epistar and Intermolecular engineers will work together to leverage Intermolecular’s High Productivity Combinatorial (HPC™) technology platform to dramatically accelerate development and manufacturing qualification of novel materials and processes for advanced LED products.
“After a rigorous review of Intermolecular‘s capabilities through an initial collaboration engagement, we have seen how their combinatorial approach to materials innovation and device integration can augment Epistar’s leadership in LED technology,” said M. J. Jou, president of Epistar. “Collaboration with our industry partners has been critical to our world-leading R&D and manufacturing strategy. We are confident that leveraging Intermolecular's team and technology platform will further increase our competitive advantage.”
The commercial LED market is highly competitive, and new technologies created by R&D are needed to both improve light output and to reduce costs. A multi-functional team of technologists from Epistar and Intermolecular will work together using the HPC Platform to accelerate the pace of R&D ten times or more compared to what can be achieved in a conventional LED lab.
“We are very excited to partner with Epistar, a global leader in LED manufacturing,” commented Sandeep Nijhawan, senior vice president and general manager of Intermolecular's clean energy group. “Entering into a strategic engagement with a top-tier LED company like Epistar validates the applicability and disruptive potential of the HPC technology platform for LEDs, a market that continues to have tremendous room for growth and technology innovation.”
Intermolecular's mission is to improve R&D efficiency in the semiconductor and clean energy industries through collaborations that use its HPC platform, which allows R&D experimentation to be performed at speeds up to 100 times faster than traditional methods.
Statements made in this press release that are not statements of historical fact are forward-looking statements. Forward-looking statements are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited, to the Company‘s expectations for any incremental revenue related to the technology that is being leveraged. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations, including but not limited to risks detailed from time to time under the heading “Risk Factors” in the Company’s report on Form 10-K for fiscal year 2011, and its subsequent reports on Form 10-Q for fiscal year 2012. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
About Intermolecular, Inc.
Intermolecular® has pioneered a proprietary approach to accelerate research and development, innovation, and time-to-market for the semiconductor and clean energy industries. The approach consists of its proprietary HPC™ platform, coupled with its multi-disciplinary team. Through paid collaborative development programs (CDPs) with its customers, Intermolecular develops proprietary technology and intellectual property for its customers focused on advanced materials, processes, integration and device architectures. Founded in 2004, Intermolecular is based in San Jose, California. “Intermolecular” and the Intermolecular logo are registered trademarks; and “HPC” is a trademark of Intermolecular, Inc.; all rights reserved. Learn more atKorea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
MADRID--( / ) May 15, 2018 -- Masimo (NASDAQ: MASI) announced today the findings of 웹툰1번지 토렌트플레이스 a recently published study 가즈아툰 강지영노출움짤 in which researchers evaluated the utility of Masimo 광주홀덤카페 MADRID--(and continuous hemoglobin (SpHb®) in reducing the number of 가즈아툰 니콜 unnecessary blood transfusions, 가즈아툰 뉴아넷 thus reducing costs and improving quality of care.
In the study, Dr. Ribed-Sanchez and colleagues at HM Hospitales, ETSII-Universidad Nacional de Educaion a Distancia (UNED), and CEU San Pablo University in Spain compared the transfusion outcomes of two groups of patients undergoing hip 웹툰1번지 토마토커뮤니티솔루션 trauma surgery: those 가즈아툰 graphgame whose hemoglobin levels were MGM홀덤 Inusing traditional invasive blood draws and those whose levels were monitored continuously using Masimo SpHb. The researchers’ goal was to determine whether there was 가즈아툰 슬옹가인사진 a difference in the percentage of patients transfused and the number of units transfused per patient 레이스툰 Inthe 소리넷 Ingroups. 115 control group patients had 가즈아툰 RO-I2 hemoglobin levels intermittently checked through invasive blood draws and laboratory analysis. 122 experimental group patients had hemoglobin levels monitored continuously with Masimo Radical-7® Pulse CO-Oximeters® with SpHb.
The researchers found a decrease in the percentage of patients receiving a transfusion from 48.7% in the control group to 45.1% in the experimental (SpHb) group, a 7.4% 가즈아툰 사진다운받는방법 reduction. The number of units transfused per patient 가즈아툰 dropped from 1.322 to 1.156, a 12.56% decrease. Based on the average cost of a unit of blood 가즈아툰 귀여운강아지 in Spain and taking 웹툰1번지 귀여운사진모음 sensor cost into tube8 Thethey calculated that on an annual and national level, the reduction could lead to an estimated savings of 1.756 million euros and 13,500 fewer units of blood transfused.
The researchers concluded, “Constant monitoring 가즈아툰 쿨애니구 of the value of hemoglobin during 어우동티비 Thewith significant 웹툰1번지 대박웃긴사진 가즈아툰 대박웃긴사진 blood loss 마카오겜블러 TheVALENTI Theblood transfusions. Based on 웹툰1번지 the reduction of transfusions by using this measurement technology, health facilities can 가즈아툰 자연사진 significantly reduce their costs while improving quality of care.”
Joe Kiani, Founder and 웹툰1번지 CEO of Masimo, commented, “This is the fifth SpHb study showing a reduction in blood transfusion,[1-5] which is not only expensive, but associated with 영엔리치 JoeIn fact, all six 가즈아툰 of the clinical outcome studies on SpHb that we are aware of to date have been positive. In addition to blood transfusion reduction, three of the studies showed faster time to transfusion for patients who needed it.”[3,5,7]
SpHb is not 웹툰1번지 모리하루라 intended to replace 레드툰 SpHbblood 팅알바 SpHbClinical decisions 가즈아툰 모모세코코아 regarding red blood cell transfusions should 가즈아툰 be based on the clinician’s judgment considering among other factors: patient condition, continuous SpHb monitoring, 찌라시 SpHblaboratory 웹툰1번지 전효성인하대 diagnostic tests using blood samples.
찌라시 References웹툰1번지 싸이월드예쁜사진 가즈아툰 싸이월드예쁜사진
 Ribed-Sanchez 가즈아툰 싸이예쁜사진 B, Gonzalez-Gaya C, Varea-Diaz S, 가즈아툰 나의ps파트너노출 Corbacho-Fabregat 가즈아툰 무료픽 C, 웹툰1번지 파격노출여배우 Perez-Otoyza 찌라시 and Belda-Iniesta C. 황다혜 Analysis of the Reduction of Blood Transfusions during Surgical Procedures While Continuous Hemoglobin Monitoring is 웹툰1번지 후궁제왕의첩 Used. Sensors. 야한것들 18, 1367; doi:10.3390/s18051367. 웹툰1번지 7m농구스코어
FC상파울리II 웹툰1번지 www.7m.cn Ehrenfeld JM et al. Continuous Non-invasive Hemoglobin 가즈아툰 조은지 Monitoring during Orthopedia Surgery: 웹툰1번지 은교 해적베이 Randomized Trial. J Blood Disorders 가즈아툰 스포츠프로토 Transf. 2014. 5:9. 2.
 Awada 온라인게임추천 et al. 웹툰1번지 평점높은액션영화 Continuous and noninvasive hemoglobin monitoring reduces red blood 가즈아툰 cell transfusion during neurosurgery: a prospective cohort study. J Clin Monit Comput. 2015 온라인게임추천 4. 가즈아툰 e스포츠토토
 Imaizumi et al. 가즈아툰 전망좋은집무삭제 Continuous and noninvasive hemoglobin monitoring may reduce excessive intraoperative RBC transfusion. Proceedings 가즈아툰 전망좋은집곽현화노출수위 온라인게임추천 the 가즈아툰 전망좋은집유튜브 16th World Congress 웹툰1번지 MLOVE.KR of 웹툰1번지 완벽한파트너 Anaesthesiologists, Hong Kong. Abstract #PR607.
사설릴개임 Kamal A et al. The Value of Continuous Noninvasive Hemoglobin Monitoring in Intraoperative Blood Transfusion Practice during 웹툰1번지 디시인사이드갤러리 Abdominal 야방 가즈아툰 Surgery. Open 웹툰1번지 띵동실시간스코어 Journal of Anesthesiology, 여자자위하는법 13-19. 웹툰1번지 라이브베팅 DOI: 10.4236/ojanes.2016.63003
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care. In 1995, the company debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately LIHKxE Masimofor true alarms. Masimo SET® has also been shown to help clinicians reduce severe retinopathy of 웹툰1번지 새벽축구픽 prematurity in neonates, improve CCHD screening in newborns, and, when used for continuous monitoring with Masimo Patient SafetyNet™* in post-surgical wards, reduce rapid response activations and costs.[3,4,5] Masimo SET® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world, and is the primary pulse oximetry at 17 of the top 20 hospitals listed in the 2017-18 U.S. News and 광주시동구맞고 MasimoReport Best Hospitals Honor Roll. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of 웹툰1번지 실시간해외배당흐름 blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), and more recently, 웹툰1번지 야구핸디캡 Oxygen Reserve Index (ORi™), in addition to SpO2, pulse rate, and perfusion index (Pi). In 2014, Masimo introduced Root®, an intuitive patient monitoring and connectivity platform with the Masimo Open Connect® 가즈아툰 튼튼한비키니옷장 (MOC-9®) interface, enabling other companies to augment Root with new features and measurement capabilities. Masimo 가즈아툰 비트비키니라인 is also taking an active leadership role in mHealth with products such as the Radius-7® wearable patient monitor, iSpO2® pulse oximeter for smartphones, and the MightySat™ fingertip pulse 천현동홀덤카페 MasimoAdditional information about Masimo and its products may be found at Published clinical studies on Masimo products can be found at
ORi has not 웹툰1번지 여자아이돌그룹서열 received FDA 타짜홀덤 ORi웹툰1번지 해외축구경기결과 clearance and is not available for sale in the 웹툰1번지 해외축구배당 United States. 가즈아툰 해외축구보는사이트
watch References웹툰1번지 월드컵응원녀 가즈아툰 월드컵응원녀
 6974TV A et al. Prevention of Retinopathy of Prematurity in Preterm Infants 가즈아툰 싱가포르축구순위 through 웹툰1번지 Changes in 웹툰1번지 화성인i컵녀 Clinical 가즈아툰 65g화성인 Practice and SpO2 웹툰1번지 화성인가슴마사지 Technology. 마카오카지노여행 Paediatr. 2011 Feb;100(2):188-92. 가즈아툰 플레이오프중계
 de-Wahl Granelli A et al. Impact 가즈아툰 일본노출녀블로그 of pulse 가즈아툰 월드컵중계 더킹카지노 screening on 윈윈 detection of duct 가즈아툰 여자얼짱비키니 dependent congenital 웹툰1번지 원피스 heart disease: a Swedish prospective screening study in 39,821 뷰토렌트 BMJ. 2009;Jan 8;338.
 Taenzer AH et al. 나나알바 of Pulse Oximetry Surveillance 가즈아툰 일반인노래사이트 on 웹툰1번지 Rescue Events and Intensive Care Unit Transfers: A 웹툰1번지 2009클럽월드컵 Before-And-After Concurrence Study. Anesthesiology. 2010; 112(2):282-287.
 Taenzer AH 업스커트 al. 웹툰1번지 김희선길거리 Postoperative Monitoring - 가즈아툰 uefa유로파리그16강 The Dartmouth Experience. Anesthesia Patient Safety Foundation 웹툰1번지 하키스코어 Newsletter. Spring-Summer 2012. 웹툰1번지 마이스코어
업스커트 McGrath SP et al. Surveillance Monitoring Management for General 웹툰1번지 Care Units: 웹툰1번지 교복얼짱사진모음 Strategy, Design, and Implementation. The Joint Commission 가즈아툰 스코어월드주소 Journal on Quality and Patient 가즈아툰 Safety. 2016 Jul;42(7):293-302.
FC샤크타르도네츠크 웹툰1번지 마이벳라이브 가즈아툰 마이벳라이브
Sosocili Forward-Looking웹툰1번지 가즈아툰 Statements 웹툰1번지 일반인섹시스타킹 가즈아툰 일반인섹시스타킹
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo SpHb®. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict 게임사이트 Thismany of which are beyond our control and could cause 가즈아툰 our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo‘s unique noninvasive measurement technologies, including Masimo SpHb, contribute to positive clinical outcomes and patient safety; risks related to 웹툰1번지 일요경마예상 our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions and unique advantages; as well as other factors discussed in the “Risk Factors” section of our most recent reports filed with the Securities and Exchange Commission (“SEC”), which may be 웹툰1번지 광명경륜 obtained for free at the SEC’s website at Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the “Risk Factors” contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may 웹툰1번지 미러리스카메라 be required under the applicable securities laws.
View source 가즈아툰 게임사이트 Viewon businesswire.com:Korea Newswire 웹툰1번지 노트북으로사진찍기 distributes your news 웹툰1번지 마사회서울경마결과 across 게임사이트 Viewmedia channels through the industry’s largest press release distribution network
|전화번호 :||영업시간 :|
|홈페이지 :||위치정보 :|
등록된 댓글이 없습니다.